PDS Biotechnology Corporation (PDSB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 35.71M |
| Enterprise Value | 25.92M |
| P/E Ratio | -0.34 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -3.4 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -3.82 |
| Return On Equity | -7.08 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -30.3M |
| Net Income | -34.5M |
| Diluted EPS | -0.74 |
| Total Cash | 5.6M |
| Total Cash/Share | 0.1 |
| Total Debt | 4.36M |
| Total Debt/Equity | -1.22 |
| Current Ratio | 0.57 |
| Book Value Per Share | -0.06 |
| 52-Week Change | -83.19 |
| 52-Week High | 1.55 |
| 52-Week Low | 0.2 |
| Moving Average 50 Days | 0.7 |
| Moving Average 200 Days | 0.85 |
| Average Volume | 1.32M |
| Shares Outstanding | 55.92M |
| % Held by Institutions | 9.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 18, 2019 |